FDA Brief

Warning letters Drugs

FDA warning letter to

Aurobindo Pharmaceutical Limited

Issued Jan 12, 2022Posted Jan 25, 2022Center for Drug Evaluation and Research | CDER

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.